ARIAD PHARMACEUTICALS INC Financing Cash Flow
ARIAD PHARMACEUTICALS INC reported Financing Cash Flow of -$90.00 thousand for the 3-month period ending 2014-03-31, per its 10-Q filed 2014-05-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2014-05-09
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2014-03-31 was -$90.00K, a 100.03% decline year-over-year.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2013-12-31 was $1.43M, a 528.63% increase year-over-year.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2013-09-30 was $2.59M, a 20.20% increase year-over-year.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for the quarter ending 2013-06-30 was -$67.00K, a 104.12% decline year-over-year.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2013 was $313.58M, a 1722.74% increase from fiscal 2012.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2012 was $17.20M, a 93.33% decline from fiscal 2011.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2011 was $258.01M, a 338.16% increase from fiscal 2010.
- ARIAD PHARMACEUTICALS INC net cash provided by (used in) financing activities for fiscal 2010 was $58.88M, a 2.50% increase from fiscal 2009.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2014-03-31 | -$90.00K 10-Q · filed 2014-05-09 | $1.34M derived: sum of 2 quarters · filed 2014-05-09 | $3.93M derived: sum of 3 quarters · filed 2014-05-09 | $3.86M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $4.02M derived: sum of 2 quarters · filed 2014-03-03 | $3.95M derived: sum of 3 quarters · filed 2014-03-03 | $313.58M 10-K · filed 2014-03-03 |
| 2013-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $2.53M derived: sum of 2 quarters · filed 2013-11-12 | $312.16M 10-Q · filed 2013-11-12 | $312.38M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-06-30 | -$67.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $309.56M 10-Q · filed 2013-08-09 | $309.79M derived: sum of 3 quarters · filed 2014-05-09 | $311.95M derived: sum of 4 quarters · filed 2014-05-09 |
| 2013-03-31 | $309.63M 10-Q · filed 2014-05-09 | $309.86M derived: sum of 2 quarters · filed 2014-05-09 | $312.01M derived: sum of 3 quarters · filed 2014-05-09 | $313.64M derived: sum of 4 quarters · filed 2014-05-09 |
| 2012-12-31 | $227.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $2.38M derived: sum of 2 quarters · filed 2014-03-03 | $4.01M derived: sum of 3 quarters · filed 2014-03-03 | $17.20M 10-K · filed 2014-03-03 |
| 2012-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $3.79M derived: sum of 2 quarters · filed 2013-11-12 | $16.98M 10-Q · filed 2013-11-12 | $259.99M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | $1.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $14.82M 10-Q · filed 2013-08-09 | $257.83M derived: sum of 3 quarters · filed 2014-03-03 | $258.78M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | $13.19M 10-Q · filed 2013-05-10 | $256.21M derived: sum of 2 quarters · filed 2014-03-03 | $257.15M derived: sum of 3 quarters · filed 2014-03-03 | $258.54M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | $243.02M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | $243.96M derived: sum of 2 quarters · filed 2014-03-03 | $245.35M derived: sum of 3 quarters · filed 2014-03-03 | $258.01M 10-K · filed 2014-03-03 |
| 2011-09-30 | $946.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $2.34M derived: sum of 2 quarters · filed 2012-11-09 | $14.99M 10-Q · filed 2012-11-09 | $72.22M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-06-30 | $1.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09 | $14.05M 10-Q · filed 2012-08-09 | $71.27M derived: sum of 3 quarters · filed 2013-03-01 | $70.96M derived: sum of 4 quarters · filed 2013-03-01 |
| 2011-03-31 | $12.66M 10-Q · filed 2012-05-09 | $69.88M derived: sum of 2 quarters · filed 2013-03-01 | $69.57M derived: sum of 3 quarters · filed 2013-03-01 | |
| 2010-12-31 | $57.22M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $56.91M derived: sum of 2 quarters · filed 2013-03-01 | $58.88M 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$316.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $1.66M 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $1.98M 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $57.45M 10-K/A · filed 2012-03-30 |